SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,379 | -99.9% | 67 | -99.8% | 0.00% | -100.0% |
| Q4 2020 | $2,610,000 | +71.0% | 29,469 | +38.1% | 0.02% | +54.5% |
| Q3 2020 | $1,526,000 | +98.2% | 21,340 | +31.2% | 0.01% | +83.3% |
| Q2 2020 | $770,000 | +37.3% | 16,268 | +10.5% | 0.01% | +20.0% |
| Q1 2020 | $561,000 | -15.8% | 14,723 | +47.8% | 0.01% | 0.0% |
| Q4 2019 | $666,000 | -38.0% | 9,960 | +31.4% | 0.01% | -37.5% |
| Q3 2019 | $1,075,000 | +214.3% | 7,580 | +302.1% | 0.01% | +166.7% |
| Q2 2019 | $342,000 | +23.0% | 1,885 | +15.9% | 0.00% | +50.0% |
| Q1 2019 | $278,000 | +39.0% | 1,626 | -0.4% | 0.00% | 0.0% |
| Q3 2018 | $200,000 | -29.1% | 1,632 | -2.1% | 0.00% | 0.0% |
| Q2 2018 | $282,000 | +14.2% | 1,667 | +14.5% | 0.00% | 0.0% |
| Q1 2018 | $247,000 | +2.1% | 1,456 | +8.4% | 0.00% | 0.0% |
| Q4 2017 | $242,000 | – | 1,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |